Literature DB >> 4358125

Viruses causing common respiratory infection in man. IV. Reoviruses and Adenoviruses.

G G Jackson, R L Muldoon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4358125     DOI： 10.1093/infdis/128.6.811

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  24 in total

1.  Adenovirus strains of subgenus D associated with nosocomial infection as new etiological agents of epidemic keratoconjunctivitis in Japan.

Authors:  S Takeuchi; N Itoh; E Uchio; K Tanaka; N Kitamura; H Kanai; K Isobe; K Aoki; S Ohno
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

2.  Reovirus as a novel oncolytic agent.

Authors:  K L Norman; P W Lee
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

3.  Blocking B7 and CD40 co-stimulatory molecules decreases antiviral T cell activity.

Authors:  J Vermeiren; J L Ceuppens; H Haegel-Kronenberger; M De Boer; L Boon; S W Van Gool
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

4.  Lobar pneumonia associated with adenovirus type 7.

Authors:  W D Leers; M K Sarin; G J Kasupski
Journal:  Can Med Assoc J       Date:  1981-11-01       Impact factor: 8.262

5.  Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin-paclitaxel doublet chemotherapy.

Authors:  V Roulstone; K Twigger; S Zaidi; T Pencavel; J N Kyula; C White; M McLaughlin; R Seth; E M Karapanagiotou; D Mansfield; M Coffey; G Nuovo; R G Vile; H S Pandha; A A Melcher; K J Harrington
Journal:  Gene Ther       Date:  2012-08-16       Impact factor: 5.250

6.  Molecular diagnosis of human adenoviruses d and e by a phylogeny-based classification method using a partial hexon sequence.

Authors:  Yasushi Shimada; Toshihide Ariga; Yoshitsugu Tagawa; Koki Aoki; Shigeaki Ohno; Hiroaki Ishiko
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

7.  REO-001: A phase I trial of percutaneous intralesional administration of reovirus type 3 dearing (Reolysin®) in patients with advanced solid tumors.

Authors:  Don G Morris; Xiaolan Feng; Lisa M DiFrancesco; Kevin Fonseca; Peter A Forsyth; Alexander H Paterson; Matt C Coffey; Brad Thompson
Journal:  Invest New Drugs       Date:  2012-08-12       Impact factor: 3.850

8.  Intravenous administration of Reolysin, a live replication competent RNA virus is safe in patients with advanced solid tumors.

Authors:  Radharani Gollamudi; Mohammad H Ghalib; Kavita K Desai; Imran Chaudhary; Benny Wong; Mark Einstein; Matthew Coffey; George M Gill; Karl Mettinger; John M Mariadason; Sridhar Mani; Sanjay Goel
Journal:  Invest New Drugs       Date:  2009-07-02       Impact factor: 3.850

9.  Reovirus infection in rat lungs as a model to study the pathogenesis of viral pneumonia.

Authors:  M J Morin; A Warner; B N Fields
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

Review 10.  Office management of lower respiratory infections in adults.

Authors:  R E Van Scoy
Journal:  Med Clin North Am       Date:  1983-01       Impact factor: 5.456
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.